Invasion and metastasis are the main causes of treatment failure and death in breast cancer. Thus, novel invasion-based therapies such as those involving natural agents are urgently required. In this study, we examined the effects of magnolol (Mag), a compound extracted from medicinal herbs, on breast cancer cells in vitro and in vivo. Highly invasive cancer cells were found to be highly sensitive to treatment. Mag markedly inhibited the activity of highly invasive MDA-MB-231 cells. Furthermore, Mag significantly downregulated matrix metalloproteinase-9 (MMP-9) expression, an enzyme critical to tumor invasion. Mag also inhibited nuclear factor-kB (NF-kB) transcriptional activity and the DNA binding of NF-kB to MMP-9 promoter. These results indicate that Mag suppresses tumor invasion by inhibiting MMP-9 through the NF-kB pathway. Moreover, Mag overcame the promoting effects of phorbol 12-myristate 13-acetate (PMA) on the invasion of MDA-MB-231 cells. Our findings reveal the therapeutic potential and mechanism of Mag against cancer.
B reast cancer is a major cancer commonly observed in women. Annually, over 1 million women worldwide are diagnosed with this disease, which is also the second most common cause of cancer-related deaths 1 . Invasion and metastasis are the main reasons for the high mortality rates associated with breast cancer and are the leading causes of poor clinical outcomes 2, 3 . Invasion and metastasis consist of several interdependent processes, including uncontrolled growth of cancer cells, migration and invasion to distant sites of surrounding tissues, as well as adhesion, invasion, and colonization of other organs and tissues 4 . Compared with other types of breast cancers, patients with highly invasive breast cancers have poor disease-free survival because of the highly invasive behavior of their disease 5 . Therefore, control of invasion and metastasis is an important therapeutic target for breast cancers.
Previous studies have proven that increased expression of matrix metalloproteinases (MMPs) is involved in tumor invasion and metastasis in many cancer types 6, 7 . To date, over 20 human MMPs have been identified 8 . Among them, MMP-2 and MMP-9 are the enzymes most crucial to tumor invasion owing to their ability to degrade extracellular matrix (ECM) and basement membrane 9 . MMP-2 is always constitutively expressed in highly metastatic tumors. Meanwhile, MMP-9 can be induced by growth factors, cytokines, or xenobiotics such as phorbol 12-myristate 13-acetate (PMA) through transcription factors [nuclear factor-kB (NF-kB) and activator protein-1 (AP-1)] 10, 11 . MMP-9 is also sufficient or necessary for metastasis to brain tissue during breast cancer progression 11 . Thus, MMP-9 can be a target of breast cancer therapy by suppressing breast cancer invasion. Magnolia officinalis belongs to family Magnoliaceae and is distributed over China, Japan, and South Korea. M. officinalis is used as a folk remedy for gastrointestinal disorders, cough, acute pain, anxiety, and allergic diseases [12] [13] [14] [15] [16] [17] [18] [19] . Magnolol (Mag; 5,59-diallyl-2,29-dihydroxybiphenyl), a hydroxylated biphenyl compound isolated from the root and stem bark of M. officinalis, is shown to have muscle relaxant, anti-oxidative, anti-atherosclerosis, anti-inflammatory, and anti-microbial effects. Mag also induces differentiation and calcium mobilization 18, 20, 21 . Recent studies have shown that Mag exhibits anti-cancer properties by inhibiting proliferation, inducing differentiation and apoptosis, suppressing angiogenesis, countering metastasis, and reversing multidrug resistance 22 . Several signaling pathways have been implicated in the regulation of apoptosis by Mag 21 . However, studies have shown that EGFR/PI3K/Akt 22 and Wnt/beta-catenin signaling 23 are involved in Mag-induced apoptosis, but the mechanisms underlying the antitumor activity of Mag remain unknown. Whether Mag has potential clinical application and anti-breast cancer activity also require further investigation. In this study, we investigated the effect of Mag against human breast cancer and the mechanisms of Mag against highly invasive breast cancer.
Results
Effects of Mag on breast cancer cell lines. We first examined the cytotoxicity of Mag on human breast cancer cell lines and normal human mammary epithelial cells (MCF-10A). By the MTT assay, we found that Mag had moderate cytotoxicity to MCF-7, SK-BR3, MDA-MB-453, MDA-MB-435S, MDA-MB-231, and MDA-MB-468 cells with an IC 50 of 24.79 mM to 59.4 mM. The IC 50 of MCF-10A was higher than those breast cancer cell lines. Among the tested breast cancer lines, highly invasive (MDA-MB-231 and MDA-MB-468) breast cancer cells were more sensitive to Mag than poorly invasive (MCF-7 and SK-BR3) cells ( Figure 1B and Table 1 ). By the MTT and Trypan Blue exclusion assays, we found that Mag inhibited the cell proliferation and growth of highly invasive estrogen receptor negative (ER-) MDA-MB-231 ( Figures 1C and  1E ) and poorly invasive ER1 MCF-7 ( Figures 1D and 1F ) cells in a time-and dose-dependent manner. Mag also suppressed the clonogenic activity of these two cell lines ( Figure 1G ). These results suggested that Mag inhibited the anchorage-dependent (cell proliferation) and anchorage-independent (colony formation) growth of highly and poorly invasive breast cancer cells, with the highly invasive breast cancer cells being more sensitive to treatment using Mag.
Effects of Mag on the invasion, migration, and adhesion of MDA-MB-231 cells. Considering that highly invasive breast cancer cells were more sensitive to treatment with Mag than poorly invasive cells, we next determined whether Mag inhibited the invasive behavior of breast cancer cells. The invasion assay was performed in highly invasive MDA-MB-231 cells using Matrigel-coated 24-well microchemotaxis chambers in the presence of Mag. As shown in Figure 2A , Mag (0 mM to 30 mM) markedly suppressed the invasion of MDA-MB-231 cells. To further explore the effect of Mag on migration, MDA-MB-231 cells were treated with Mag (0 mM to 30 mM), and cell migration was determined after 24 h. As shown in Figure 2B , Mag significantly decreased MDA-MB-231 cell migration in a dosedependent manner. Finally, we evaluated the effect of Mag on cell adhesion. As shown in Figure 2C , Mag also inhibited the adhesion of MDA-MB-231 cells onto the Matrigel in a concentration-dependent manner compared with the untreated control. These results suggested that Mag exhibited anti-invasive behavior toward breast cancer at non-cytotoxic concentrations.
Mag suppresses the invasion of MDA-MB-231 cells by inhibiting MMP-9 through the NF-kB pathway. Cancer invasiveness and metastasis are associated with increased expression of MMPs 11, 24 . MMP-2 and MMP-9 are the key enzymes expressed in breast cancer cells, and their proteolytic activity contributes to cell invasion and metastasis [25] [26] [27] . Therefore, we determined whether the inhibition of the invasive behavior of breast cancer cells by Mag can be mediated by suppressing MMP-2 and MMP-9 activities in MDA-MB-231 cells. Gelatin zymography was performed using the conditioned medium (CM) from the Mag-treated cells. As shown in Figure 3A , Mag markedly reduced the gelatinolytic activity of MMP-9 from MDA-MB-231 cells, suggesting that Mag inhibited the invasiveness of breast cancer cells by the inhibition of MMP-9 activity. Consistent with the inhibition of gelatinolytic activity, Western blot analysis of the CM also revealed that Mag downregulated the level of MMP-9 secretion ( Figure 3B ). To determine whether the inhibitory effect of Mag on MMP-9 secretion resulted from a downregulated level of MMP-9 mRNA expression, real-time PCR was conducted. Results confirmed that Mag significantly downregulated MMP-9 mRNA expression levels ( Figure 3C ). These results indicated that the Mag-mediated regulation of MMP-9 expression occurred at the transcriptional level, and the downregulation of MMP-9 inhibited the invasion of MDA-MB-231 cells.
The NF-kB and AP-1 pathways are critical transcription factors in the regulation of MMP-9 expression 27, 28 . To further understand the inhibitory mechanisms of Mag on MMP-9 transcriptional regulation, the NF-kB and AP-1 pathways were investigated by Western blot analysis as well as reporter and ChIP assays. As shown in Figures 3D to 3F , Mag inhibited the phosphorylation of IkBa (pIkBa) and P65 (pP65) in MDA-MB-231 cells and prevented the translocation of P65 from cytoplasm to nucleus. This phenomenon indicated that IkBa degradation and P65 translocation from cytoplasm to nucleus was blocked by Mag. Mag inhibited NF-kB transcription activity at 20 and 30 mM ( Figure 3G ) and the DNA binding of NF-kB to MMP-9 promoter at 20 mM ( Figure 3H ). AP-1, known to be regulated by MAPKs such as ERK, JNK, and P38 kinase, is another transcription factor involved in the activation of MMP-9 transcription 25, 29 . Therefore, Mag may act through the AP-1 pathway to inhibit MMP-9 gene expression. To investigate this possibility, we first examined the effect of Mag on the transcriptional activity of AP-1 and on the phosphorylation of MAPK family members. As shown in Figure 3I , Mag exerted no effect on AP-1 transcriptional activity. The phosphorylation of P38, ERK, and JNK was not significantly affected by Mag, and the respective total protein levels of these MAPKs remained unchanged ( Figure 3J ). These results indicated that the NF-kB pathway mediating MMP-9 mRNA expression was inhibited by Mag, and Mag-induced invasive behavior inhibition was an NF-kB-dependent event.
Mag overcame the promoting effects of PMA on the invasion of MDA-MB-231 cells. PMA has been shown to enable breast cancer cell invasion through the induction of the NF-kB and/or AP-1 signaling pathways to mediate MMP-9 transcription 30 . Accordingly, we determined whether Mag can abrogate the promoting effects of PMA on MDA-MB-231 cells. Interestingly, we found that Mag abrogated PMA-induced invasion ( Figure 4A ) by downregulating MMP-9 gelatinolytic activity ( Figure 4B ), MMP-9 mRNA expression ( Figure 4C ), and protein expression from CM ( Figure 4D ). We then examined the effects of Mag on NF-kB and AP-1 signal cascades, which play a major role in MMP-9 transcription. Our results showed that in MDA-MB-231 cells, pIkBa and pP65 were upregulated by treatment with PMA at 80 nM. Interestingly, pretreatment with Mag (0 mM to 30 mM for 12 h) markedly inhibited the PMA-induced upregulation of pIkBa and pP65 ( Figure 4E ). In addition, we tested NF-kB transcriptional activity by the luciferase reporter assay, and the result also showed that Mag significantly inhibited PMA-induced NF-kB transcriptional activity ( Figure 4F ). We further investigated the effect of Mag on the PMA-induced upregulation of the phosphorylation of P38, ERK, and JNK as well as on AP-1 transcriptional activity (Figures 4G and 4H) . Results showed that Mag did not drastically affect the AP-1 signal cascades. These results indicated that Mag can overcome the facilitative effects of PMA on MDA-MB-231 cells by blocking NF-kB-mediated MMP-9 transcription. Taken together, our results demonstrated that the invasiveness of breast cells was weakened by a dose of Mag mainly through the NF-kB signaling pathway, which regulates MMP-9 ( Figure 5 ).
Effect of Mag on breast cancer xenograft tumor growth in vivo. To evaluate the effect of Mag in vivo, MDA-MB-231 xenografted and MCF-7 xenografted murine models were generated. Tumor-bearing mice were treated with vehicle (MDA- Figures 6E and 6F) . The tumor samples of mice bearing MDA-MB-231 cells were isolated, cells were harvested, and experiments were conducted to determine whether Mag perturbed MMP-9 expression in vivo. Interestingly, samples from mice treated with Mag showed downregulated MMP-9 levels compared with tumor tissues from vehicle mice ( Figures 6G and  6H ). These results demonstrated that the administration of Mag had great potential in breast cancer therapy. Discussion Natural sources continue to provide front-line pharmacotherapy for millions of people worldwide 18, 21, 22, 31 . In this study, we reported for the first time the effect of Mag, a hydroxylated biphenyl compound isolated from the root and stem bark of M. officinalis, on the growth and invasive behavior of breast cancer cells. Several studies have documented the anti-cancer activity of Mag 31 . For example, Maginduced apoptosis in HCT-116 colon cancer cells was associated with the AMP-activated protein kinase signaling pathway 20 . In PC-3 prostate carcinoma cells, Mag reduced MMP-2/-9 and cyclooxygenase-2 at the mRNA level 32 . In the current work, we showed that Mag significantly inhibited breast cancer cell proliferation, growth, and colony formation, as well as suppressed tumor growth in a xenograft model of human breast cancer, suggesting its potential in breast cancer control.
Tumor invasion is a common feature of triple-negative breast cancers 33 . Triple-negative breast cancers (12% to 24% of breast cancers) 34 , which are characterized by the absence of ER, progesterone receptor, and HER-2 expression, result in high morbidity and mortality owing to their rapid growth rate, invasive potential, and frequently acquired treatment resistance. Migration and invasion are becoming important prerequisites of cancer progression and metastasis. Therefore, therapeutic strategies for preventing or suppressing cancer invasion and metastasis can significantly improve the survival of triple-negative breast cancer patients. The present data showed that Mag markedly inhibited the invasive ( Figure 2A ) and migratory ( Figure 2B ) abilities of MDA-MB-231 cells. In addition, the adhesion of cancer cells onto ECM and their interactions were crucial steps in the metastatic and invasion processes 35 . We reported that Mag treatment markedly inhibited cell adhesion onto matrigel ( Figure 2C ).
MMPs are a family of metal-containing enzymes, and among them, MMP-2 and MMP-9 are highly expressed in invasive breast cancer cells 11, 25 . Evidence on the important role of MMP-9, known as a gelatinase B, in the invasive potential of tumors in vitro and in vivo has been reported [25] [26] [27] . The current study demonstrated that Mag treatment inhibited the gelatinolytic activity and expression of MMP-9 at the protein and mRNA levels in MDA-MB-231 cells compared with untreated control (Figures 3A to 3C) . Therefore, MMP-9 may be a Mag-responsive mediator whose degradation of ECM may cause subsequent cancer migration and invasion.
The MMP-9 promoter region contains the cis-regulatory element, including one NF-kB and two AP-1 binding sites 36, 37 . Thus, we investigated the effects of Mag on NF-kB and AP-1 signal cascades, which play major roles in MMP-9 transcription. The activation of NF-kB confers growth/survival, invasion, and metastasis advantages, as well as drug resistance to many cancers 38 . NF-kB is activated by the phosphorylation-induced degradation of IkBs, which facilitates the dissociation of NF-kB from IkB family proteins. In this study, NF-kB but not AP-1 was found to modulate Mag-reduced MMP-9 activity. Our results also demonstrated that Mag exerted anti-NF-kB effect by blocking IkBa phosphorylation and P65 phosphorylation without affecting total IkBa and P65 expression ( Figure 3D ). Mag inhibited NF-kB transcriptional activation ( Figure 3G ) and DNA binding to MMP-9 promoter ( Figure 3H ). However, Mag exerted no effect on AP-1 transcriptional activation ( Figure 3I ). Parallel to this observation, the phosphorylation of ERK, JNK, and P38 kinase, which are known upstream molecules of AP-1, were unaffected by Mag ( Figure 3J ). Taken together, our findings demonstrated that the anti-invasive effect of Mag may be mediated by inhibiting NF-kBbinding activities and suppressing the NF-kB/IkB pathway.
Previous studies have shown that PMA can be used as a tumor promoter in chemically induced carcinogenesis in vitro and in vivo 25, 29, 39 . PMA can promote tumor migration and invasion by stimulating MMP-2 or MMP-9 expression through the induction of the NF-kB and/or AP-1 signaling pathways in colon, hepatoma, glioma, and breast cancer cells 10 . To investigate the inhibitory effect of Mag on PMA-induced MMP mRNA, we found that PMA induced the invasion of MDA-MB-231 ( Figure 4A ) breast cancer cells by inducing MMP-9 expression at both the mRNA and protein levels in a dose-dependent manner, indicating that impaired MMP-9 activity resulted from the downregulation of MMP-9 gene expression ( Figures 4B to 4D ). NF-kB and AP-1 contributed to the effect of MMP-9 gene through PMA 25, 40 . As shown in Figures 4B to 4F , the inhibitory effect of Mag on MMP-9 enzyme activity at both mRNA and protein levels indicated that Mag abrogated the promoting effect of PMA on MDA-MB-231 cells by inhibiting NF-kB signaling pathway-mediated MMP-9 gene expression. However, Mag did not affect the stimulation of PMA on AP-1 and its upstream MAPK family members. Previous studies have reported that NF-kB plays a regulatory role in PMA-induced MMP-9 expression in breast cancer cells, whereas AP-1 exerted a negligible effect. Our data suggested that the NF-kB pathway was the main regulatory pathway in suppressing PMA-induced MMP-9 gene expression and invasion by Mag.
In conclusion, the polyphenolic compound Mag isolated from traditional Chinese medicine inhibited the NF-kB signaling pathway and resulted in the suppression of MMP-9 at the mRNA and protein levels. We also showed for the first time that Mag inhibited PMAinduced breast cancer cell invasion by MMP-9 expression. These findings suggested that this compound was a novel promising anticancer and anti-invasion compound. Moreover, Mag was a new potential therapeutic agent for patients with breast cancer, particularly highly invasive breast cancer.
Methods
Reagents. Mahnolol (Mag) with a purity of up to 98% was purchased from Shanghai Yuanye Bio-Technology Co., Ltd. Mag was dissolved in DMSO (Sigma) at a stock solution of 100 mM and stored at 220uC. Phorbol 12-myristate 13-acetate (PMA) was purchased from Sigma-Aldrich.
Cell culture. Human breast cancer cell lines MCF-7, MDA-MB-231, SK-BR3, MDA-MB-468, MDA-MB-453, and MDA-MB-435S and Non-tumorigenic MCF-10A human mammary epithelial cells were obtained from American Type Culture Collection (ATCC). MCF-7 and SK-BR3 cells were maintained in Dulbecco's modified Eagle's medium (DMEM)(Gibco) supplemented with 10% fetal bovine serum FBS (Hyclone) and antibiotics and incubated in a humidified atmosphere with 5% CO 2 at 37uC. MDA-MB-231 and MDA-MB-468 (triple-negative and highly invasive human breast cancer cell line), MDA-MB-453, and MDA-MB-435S cells were maintained in Leibovitz's-15 (L-15) (Gibco) supplemented with 10% FBS and antibiotics and incubated in a humidified atmosphere without CO 2 at 37uC. MCF-10A cells were maintained in DMEM/F12 medium containing 5% horse serum (HS), insulin (10 mg/ml), epidermal growth factor (EGF, 20 ng/ml), choleratoxin (100 mg/ml), hydrocortisone (0.5 mg/ml), penicillin (50 U/ml), and streptomycin (50 U/ml), and incubated in a humidified atmosphere without CO 2 at 37uC.
Cytotoxic assay and cell viability. Cells were seeded into 96-well plate and precultured for 24 h, then treated with Mag for 24 or 48 h. Cell cytotoxicity was determined by MTT assay. The absorbance was measured at 570 nm by Automated Microplated Reader (Bio-Tek, VT, USA), and the cell death rate was calculated as followed: Cell death (%) 5 (average A 570 of the control group -average A 570 of the experimental group)/(average A 570 of the control group -average A 570 of the blank group) 3 100% 23 . Cell viability was estimated by trypan blue dye exclusion 41 .
Soft-agar colony formation assay. Cells were suspended in 1 ml of DMEM or L-15 containing 0.3% low-melting-point agarose (Amresco, USA) and 10% FBS, and plated on a bottom layer containing 0.6% agarose and 10% FBS in 6-well plate in triplicate. After 2 weeks, plates were stained with 0.2% gentian violet and the colonies were counted under light microscop 42 .
Invasion assay. An invasion assay was carried out using 24-well plate (Corning). A polyvinyl-pyrrolidone-free polycarbonate filter (8 mm pore size) (Corning) was coated with matrigel (BD). The lower chamber was filled with medium containing 20% FBS as chemoattractant agents. The coated filter and upper chamber were laid over the lower chamber. Cells (1 3 10 4 cells/well) were preincubated with Mag for 30 min at room temperature, and then cell suspension containing Mag was seeded onto the upper chamber wells. After incubation for 20 h at 37uC, the filter was fixed and stained with 2% ethanol containing 0.2% crystal violet (15 min). After being dried, the stained cells were enumerated under light microscope at 10 3 objective. For quantification, the invaded stained cells on the other side of the membrane were extracted with 33% acetic acid. The absorbance of the eluted stain was determined at 570 nm. Wound healing assay. Cells (4 3 10 5 cells/2 ml) were seeded in a 6-well plate and incubated at 37uC until 90% to100% confluent. After the confluent cells were scratched with a 200 ml pipet tip, followed by washing with PBS, and then treated with Mag in a complete medium. After 24 h of incubation, the cells were fixed and stained with 2% ethanol containing 0.2% crystal violet powder (15 min), and randomly chosen fields were photographed under a light microscope at 43 objective. The number of cells migrated into the scratched area was calculated. Gelatin zymography. MDA-MB-231 cells were seeded in 6-well plates and allowed to grow to 80% confluency. The cells were then maintained in serum-free medium for 12 h prior to designated treatments with Mag and PMA for 20 h. Conditioned medium was then collected, cleared and mixed with 5 3 SDS loading buffer, and subjected to electrophoresis on a 10% SDS-PAGE gel containing 0.1% gelatin. After electrophoresis, the gels were washed in renaturing buffer (pH 7.5, 2.5% Triton X-100) for 30 min, 4 times, and equilibrated in developing buffer (50 mM Tris-HCl pH 7.5, 10 mM CaCl 2 , and 1 mM ZnCl 2 ) for 30 min and finally incubated in fresh developing buffer at 37uC for 24 h to allow digestion of the gelatin. The gelatinolytic activity of MMPs was visualized by staining the gels with 0.5% Coomassie blue R-250 in 45% methanol, 10% acetic acid and destained with 45% methanol, 10% acetic acid until clear bands suggestive of gelatin digestion appeared.
Real-time quantitative PCR. Expression of the MMP-9 gene was examined by realtime polymerase chain reaction (PCR) normalized to expression of GAPDH. Total RNA was extracted from cell lines or patients' cells using Trizol reagent (Invitrogen). Quantitative real-time PCR was performed using SYBR Premix Ex Taq (Perfect Real Time) (TaKaRa Code: DRR041) according to the manufacturer's instruction 43 . For real-time PCR, we used MMP-9 gene forward primer 59-GAGTGGCAGGGGGA AGATGC-39, MMP-9 gene reverse primer 59-CCTCAGGGCACTGCAGGATG-39; GAPDH forward primer 59-TGTTGCCATCAATGACCCCTT-39, GAPDH reverse primer 59-CTCCACGACGTACTCAGCG-39.
Western blot. Cell pellets were lysed in RIPA buffer containing 50 mM Tris pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% deoxycholate, 1% NP-40, 1 mM DTT, 1 mM NaF, 1 mM sodium vanadate, 1 mM PMSF (Sigma), and 1% protease inhibitors cocktail (Merk). Protein extracts were quantitated and loaded on 8% to 12% sodium dodecyl sulfate polyacrylamide gel, electrophoresed, and transferred to a PVDF membrane (Millipore). The membrane was incubated with primary antibody, washed, and incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (Pierce). Detection was performed by using a chemiluminescent Western detection kit (Cell Signaling) 44 . The antibodies used were anti-MMP-9, anti-IkBa, anti-P65 (Santa Cruz Biotechnology), anti-P38, anti-pP38 (Thr180/Tyr182), anti-ERK1/2, anti-pERK1/2 (Thr202/Tyr204), anti-JNK1/2, and anti-pJNK1/2 (Thr183/Tyr185) (Cell Signaling Technology), anti-pIkBa (Ser32), anti-pP65 (Ser536), anti-MMP-2 (Epitomics), and anti-GAPDH (Sangon Biotech., AB10016) antibodies.
Isolation of nuclear and cytoplasmic fractionation. Nuclear and cytoplasmic extracts were prepared with the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific). The purity of nuclear and cytoplasmic extracts was assessed by Western blot with anti-lamin B (cell signaling) and anti-GAPDH antibodies, respectively.
Immunofluorescence staining. MDA-MB-231 cells were incubated in the presence or absence of Mag for 24 h. Cells were then fixed and penetrated. A primary antibody against P65 was added at a dilution of 15500 and incubated with cells at 4uC overnight. A FITC conjugated goat anti-rabbit IgG antibody was used as the secondary antibody. For visualization of cell nucleus, DAPI was used. Sections were observed using an Olympus laser scanning confocal microscope with an imaging software (Olympus Fluoview FV-1000, Tokyo, Japan).
NF-kB and AP-1 luciferase reporter assay. MDA-MB-231 cells were seeded in 12-well culture plates. At a confluency of 70%, cells were transfected with the pNF-kBLuc or pAP-1-Luc plasmids (Beyotime Institute of Biotechnology) using the Lipofectamine 2000 (Invitrogen) according to manufacturer's instruction. After transfection for 4 h, the cells were treated with Mag for 20 h or pretreated with Mag for 30 min followed by PMA stimulation for another 20 h. Firefly luciferase activities were assayed using the Luciferase Assay System (Promega) according to the manufacturer's instructions.
Chromatin immunoprecipitation (ChIP) assay. MDA-MB-231 cells treated with Mag for 24 h were processed for ChIP assay using a ChIP-IT Express Enzymatic kit (Active Motif). Briefly, immunoprecipitation was performed with NF-kB p65 or rabbit IgG as a control. The NF-kB binding site of MMP-9 promoter was detected by PCR using the following primers: 59-GACCAAGGGATGGGGGATC-39 and 59-CTTGACAGGCAAGTGCTGAC-39.
Human breast cancer xenograft experiments. Female nude immunodeficient mice (nu/nu), 6-8 weeks old, were purchased from Guangdong Province Medical Animal Center, and maintained and monitored in a specific pathogen-free environment. All animal studies were conducted according to protocols approved by the Tsinghua University Animal Care and Use Committee, complying with the rules of REGULATIONS FOR THE ADMINISTRATION OF AFFAIRS CONCERNING EX-PERIMENTAL ANIMALS (Approved by the State Council of China). The mice were injected subcutaneously with human breast cancer MDA-MB-231 cells (6 3 10 6 ) or MCF-7 (4 3 10 6 ) suspended in 100 ml L-15 or DMEM media into the right flank of each mouse 45 . Treatments were started when the tumors reached a palpable size. Mice were randomly divided into two groups (n 5 6-10) and treated 4 times per week. The control group received vehicle (0.8% DMSO/12% Cremophor/8% Ethanol in normal saline), while another group received intraperitoneally (i.p.) injection of Mag (40 mg/kg). Caliper measurements of the longest perpendicular tumor diameters were performed twice a week to estimate the tumor volume, using the following formula: 4p/3 3 (width/2) 2 3 (length/2), representing the 3-dimensional volume of an ellipse. Animals were sacrificed when tumors reached 1.5 cm or if the mice appeared moribund to prevent unnecessary morbidity to the mice. At the time of the animals' death, tumors were excised, cells were lyzed for Real-time PCR or immunofluorescence.
Tumor immunofluorescence staining. Surgically excised tumors were cryosectioned to 7 mm thick sections. Then the frozen sections were thawed and fixed with 4% paraformaldehyde for 30 min. After blocking with 3% BSA/0.2% Triton X-100 in PBS for 1 h, sections were incubated with anti-MMP-9 antibody at 4uC overnight. Cy3 conjugated donkey anti-goat IgG antibody were used as the secondary antibody. For visualization of cell nucleus, DAPI was used. Sections were observed by Olympus confocal laser scanning microscope.
Statistical analysis. All experiments were repeated at least three times and the data were presented as the mean 6 SD unless noted otherwise. Differences between data groups were evaluated for significance using Student t-test of unpaired data or oneway analysis of variance and Bonferroni post-test. The tumor volume was analyzed with two-way ANOVA and independent sample t test using the software SPSS 12.0 for Windows (Chicago, IL). P values less than 0.05 indicate statistical significance.
